Safety and efficacy of [Y-90-DOTA,Tyr(3)]-octreotide (Y-90-SMT487; OctreoTher) peptide receptor radionuclide therapy (PRRT). Preliminary results of a phase-1 study
(2001)
Files
No attached file found for this publication.
Details
- Authors
- Affiliations
Citations
Valkema, R., Jamar, F., Pauwels, S., Bakker, W., Norenberg, J., Smith, C., Stolz, B., Kvols, L., & Krenning, E. (2001). Safety and efficacy of [Y-90-DOTA,Tyr(3)]-octreotide (Y-90-SMT487; OctreoTher) peptide receptor radionuclide therapy (PRRT). Preliminary results of a phase-1 study. European journal of nuclear medicine, 28(8), 1025. (Original work published 2001)